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In situ forming hydrogels, which allow for the modulation of physico-chemical properties, and in which
cell response can be tailored, are providing new opportunities for biomedical applications. Here, we
describe interpenetrating polymer networks (IPNs) based on a physical network of calcium alginate
(Alg-Ca), interpenetrated with a chemical one based on hydroxyethyl-methacrylate-derivatized dextran
(dex-HEMA). IPNs with different concentration and degree of substitution of dex-HEMA were character-
ized and evaluated for protein release as well as for the behavior of embedded cells. The results demon-
strated that the properties of the semi-IPNs, which are obtained by dissolution of dex-HEMA chains into
the Alg-Ca hydrogels, would allow for injection of these hydrogels. Degradation times of the IPNs after
photocross-linking could be tailored from 15 to 180 days by the concentration and the degree of substi-
tution of dex-HEMA. Further, after an initial burst release, bovine serum albumin was gradually released
from the IPNs over approximately 15 days. Encapsulation of expanded chondrocytes in the IPNs revealed
that cells remained viable and, depending on the composition, were able to redifferentiate, as was dem-
onstrated by the deposition of collagen type II. These results demonstrate that these IPNs are attractive
materials for pharmaceutical and biomedical applications due to their tailorable mechanical and degra-
dation characteristics, their release kinetics and biocompatibility.
 2010 Acta Materialia Inc. Published by Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Hydrogels are commonly studied in the pharmaceutical ﬁeld as
materials for the controlled release of bioactive molecules, i.e. pro-
teins, as well as in the tissue engineering ﬁeld for encapsulation of
cells [1,2]. Hydrogel networks can be obtained by chemical or phys-
ical cross-linking ofwater-solublemacromolecules [3,4]. Because of
their hydrophilic nature, hydrogels are able to retain large amounts
of water, thereby mimicking natural tissues. Particularly, hydrogels
made of polysaccharides are attractive because of their abundance,
possibilities for chemical derivatization and, generally, good bio-
compatibility [5,6]. Amongst the various hydrogels described in
the literature, particular attention has been given in recent years
to in situ forming hydrogels [7–10]. These formulations can be
administrated by injection in the therapeutic target, after which
gelation takes place and the locally formed gel can act as a depot
system for release of drugs or bioactive compounds. The use of
hydrogels can improve efﬁcacy, efﬁciency, patience complianceElsevier Ltd.
: +39 06 49913133.
Matricardi).
Open access under the Eof the therapeutic agent and reduce, in most cases, its toxicity
[3,7,11]. In situ gelling hydrogels are also interesting materials for
tissue engineering applications, where they can be injected into
thedefect site and, after gelation,mimic the extracellularmatrix act-
ing as scaffold for proliferation anddifferentiation of entrapped cells
[12,13].
In order to modulate the properties of the networks, a new class
of hydrogels based on the interpenetration of two different poly-
mer networks (IPNs) has been developed recently [14–17]. An
IPN consists of two or more hydrophilic polymers, each forming
either physically or chemically cross-linked networks which are
entangled with each other. A semi-IPN, instead, is composed of
one cross-linked polymer system in which free polymer chains
are dissolved.
In IPNs, neither chemical nor strong physical interactions are
present between the two networks. Nevertheless, both polymers
contribute, sometimes in a synergistic way, to the physico-chemi-
cal and e.g. drug delivery properties of the IPN [18].
Recently, we described IPN hydrogels based on calcium alginate
(Alg-Ca) and dextran methacrylate derivatives (dex-MA) [19,20].
The physico-chemical characteristics of the semi-IPNs (Alg-Calsevier OA license.
Fig. 1. Chemical structure of dextran derivatized with hydrolyzable hydroxyeth-
ylmethacrylate moieties.
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after UV curing) were described [19,20]. These systems showed
interesting properties including injectability, improved mechanical
strength in comparison to the two separate hydrogel systems, aris-
ing from the synergistic interaction between the polymer net-
works, and tunable protein release properties. The high viscosity
of the semi-IPNs, the ease of manipulation and UV curing possibil-
ities make the system useful for in situ hydrogel formation.
However the dex-MA hydrogels are not biodegradable under phys-
iological conditions [11], limiting their application in the biomed-
ical and pharmaceutical ﬁelds. Therefore, in the present work,
polysaccharide IPNs based on alginate and biodegradable dex-
HEMA (Fig. 1) [21,22] were evaluated for their mechanical and
release properties, cytocompatibility and their ability to act as scaf-
fold for tissue engineering applications.2. Materials and methods
2.1. Materials
Dextran (dex) samples from Leuconostoc ssp. with molecular
weight (Mw) of 40  103, 4-N,N-dimethylaminopyridine (4-DMAP),
and hydroxyethyl methacrylate (HEMA) were Fluka products. So-
dium alginate (Alg) with Mw of 150  103 (70% L-guluronic acid
and 30% D-mannuronic acid), carbonyldiimidazole (CDI), bovine
serum albumin (BSA), (4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid (HEPES) buffer, ethylenediaminetetraacetic acid
(EDTA), ascorbic acid 2-phosphate, haematoxylin, DAB, haematox-
ylin, eosin, fast green FCF and safranin O were all provided by Sig-
ma–Aldrich, USA. Irgacure 2959 (2-hydroxy-4b-(2-hydroxyetoxy)-
2-methyl-propiophenone) was obtained from Ciba Specialty
Chemicals Inc. Collagenase type II was provided by Worthington
Biochemical, Lakewood, USA. Phosphate buffered saline (PBS),
DMEM, penicillin, streptomycin, 1 ITS-X and trypsin were ob-
tained from Invitrogen (USA). Fetal bovine serum (FBS) was a Bio-
whittaker product. bFGF and TGF-b2 were provided by R&D
Systems (USA). Human serum albumin was a product of SeraCare
Life Sciences (USA). All other chemicals were analytical grade.2.2. Methods
2.2.1. Dex-HEMA synthesis and characterization
Dex-HEMA batches were prepared by functionalizing dextran
according to a previously described method [21]. In short, ﬁrst
HEMA is activated with CDI (resulting in HEMA-CI), which in a sec-
ond step was coupled to the hydroxyl groups of dextran. The de-
gree of substitution (DS, i.e. the number of HEMA groups per 100
glucopyranose residues of dextran) was determined by 1H nuclear
magnetic resonance (NMR) in D2O using a Gemini 300 MHz spec-
trometer (Varian Associates Inc., NMR instruments, Palo Alto,
CA). Dex-HEMA with DS = 8, 12, and 16 were prepared.2.2.2. Hydrogel preparation
In the IPNs, the Alg concentration was ﬁxed at 3% (w/v), while
three different dex-HEMA concentrations, 10% (w/v), 15% (w/v)
and 20% (w/v), respectively, were used.
Hydrogels (1 ml) were formed in cylindrical vials (diameter
12 mm) as follows. Alg-Na (0.030 g) was dissolved in 0.6 ml of
HEPES buffer (100 mM, pH 7.4). Next, an appropriate amount of
dex-HEMA was added followed by the addition of 3 ll of a concen-
trated solution (33% w/v) of the photoinitiator Irgacure 2959. Then,
0.4 ml of a CaCl2 solution (0.025 M) also containing NaCl (0.385 M)
was added to the alginate/dex-HEMA solution. The system was
mixed by mechanical stirring resulting in the formation of the
semi-IPN, which was subsequently irradiated with a BluePoint 4
mercury lamp (Honle UV technology, k range 350–450 nm, light
intensity of 400 mW cm2), for 5 min to polymerize dex-HEMA
and to yield the IPNs. Table 1 gives the compositions of the inves-
tigated hydrogels.
For release studies, BSA was loaded into the IPNs by dissolving
10 mg protein in 200 ll of HEPES, which was subsequently added
to the alginate/dex-HEMA solution. In order to avoid UV-induced
protein degradation, a glass ﬁlter was interposed between the sam-
ple and the UV lamp.2.2.3. Rheological experiments
Oscillatory shear experiments were performed using an AR-G2
rheometer (TA-Instruments). Frequency sweeps of the semi-IPNs
were carried out using a cone-plate geometry (diameter = 20 mm;
cone = 1) in the range 0.01  10 Hz, which is in the linear visco-
elastic region as assessed by stress/sweep experiments. To prevent
water evaporation from the samples, a solvent trap was used. The
polymerization kinetics were followed using a UHP device con-
nected to a BluePoint 4 mercury lamp (Honle UV technology, k
range 230–500 nm, intensity of 50 mW cm2), setting the gap to
500 lm and starting irradiation after 180 s from the start of the
rheological experiment. During the UV irradiation of the samples
for 7 min, G
0
(storage modulus) and G0 0 (loss modulus) were moni-
tored at a strain of 0.1% and a frequency of 1 Hz. Next, the visco-
elastic properties of the IPNs were recorded in the range of 0.01–
10 Hz, applying a constant deformation in the linear regime (1%).
All measurements were performed at 25 C.2.2.4. DMA measurements
The Young’s moduli (E0) of the hydrogels were determined by
dynamic mechanical analysis (DMA), performed with a DMA
2980 dynamic mechanical analyzer (TA Instruments, New Castle,
DE, USA) equipped with a compression clamp (upper plate 6 mm,
lower plate 45 mm). Experiments were performed at room temper-
ature by imposing a range of frequencies (from 10 to 0.1 Hz), an
amplitude of 20 lm with a constant preload force of 0.01 N. For
each formulation, the reported data are the mean of four indepen-
dently prepared samples.2.2.5. Methacrylic conversion
The hydrogels were incubated in 9 ml of 0.02 M NaOH at 37 C
for 24 h to hydrolyze unreacted methacrylic groups [23]. Next,
1 ml of 2 M acetic acid solution was added and themethacrylic acid
concentration was determined using an Acquity UPLC trade,
equipped with a UV detector operating at 210 nm, utilizing a BEH
C18 1.7 lm, 2.1  50 mm column. The eluent was H2O/acetoni-
trile/perchloric acid (95/5/0.1%) and the ﬂow rate was 0.5 ml min1.
The methacrylate conversion is deﬁned as (1  (moles of unreacted
methacrylate groups/moles of methacrylate groups originally cou-
pled to dextran)  100).
Table 1
Composition of the samples prepared.
% Polymer concentration (w/v)
Sample Alginate Dextran Dex-HEMA DS 8% Dex-HEMA DS 12% Dex-HEMA DS 16%
A3D108 3 – 10 – –
A3D158 3 – 15 – –
A3D208 3 – 20 – –
A3D1012 3 – – 10 –
A3D2012 3 – – 20 –
A3D1016 3 – – – 10
A3D2016 3 – – – 20
A3Dex 3 20 – – –
Alg3-Ca 3 – – – –
D108 – – 10 – –
D208 – – 20 – –
D1012 – – – 10 –
D2012 – – – 20 –
D1016 – – – – 10
D2016 – – – – 20
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IPNs of Alg-Ca and dex-HEMA were weighed and transferred
into pre-weighed glass vials. Next, 6 ml of 100 mM HEPES buffer
(pH 7.4) with 0.02% NaN3 was added and the gels were incubated
at 37 C. The hydrogels were weighed at regular time intervals
after removal of the excess of buffer, until their complete dissolu-
tion in the incubation buffer [24]. After each measurement, 6 ml of
fresh buffer was added. The hydrogel swelling is deﬁned as the ra-
tio Wt/W0, where W0 and Wt are the hydrogel weight after prepa-
ration and at time t, respectively. The swelling/degradation
experiments were performed in duplicate.
IPNs were also incubated in 6 ml of EDTA (70 mM) in HEPES
buffer pH 7.4 for 48 h, changing the buffer three times per day.
Subsequently, the IPNs were weighed.2.2.7. Protein release
Hydrogels with a BSA concentration of 10 mg ml1 were pre-
pared as described above. The obtained IPNs were transferred into
20 ml glass vials and 6 ml of 100 mM HEPES buffer pH 7.4 plus
0.02% NaN3 was added and the IPNs were incubated at 37 C. Sam-
ples of the release medium (1 ml) were taken at appropriate time
intervals (the ﬁrst day after 1, 3, 5, and 24 h, and subsequently once
a day) and replaced by an equal volume of fresh buffer. The protein
concentration in the different samples was determined by using an
Acquity UPLC trade, BEH C18 1.7 lm, 2.1  50 mm column and a
UV detector working at 210 nm. An eluent gradient, from 0% to
100% of eluent A was used, where A is H2O/acetonitrile/perchloric
acid (95/5/0.1%) and eluent B is acetonitrile/perchloric acid (100/
0.1%).The injection volumes of the samples were 7.5 ll and the
ﬂow rate was 0.25 ml min1. For an appropriate comparison, BSA
release from Alg-Ca hydrogels and from dex-HEMA hydrogels
was followed.Fig. 2. (A) Storage modulus G0 and loss modulus G0 0 as a function of frequency for
(.) A3Dex; (D) Alg3-Ca; (j) A3D108; () A3D158; (d) A3D208. (B) Storage modulus G0
at 1 Hz of semi-IPNs of Alg-dex-HEMA as a function of the DS of dex-HEMA at a
ﬁxed dex-HEMA concentration of 20% (w/v).2.2.8. Cell culture experiments
Full thickness healthy articular cartilage was obtained from the
femoropatellar joints of fresh equine cadavers (n = 2, age: 2 years)
under aseptic conditions [25]. Cartilage was digested overnight
using 0.15% collagenase type II at 37 C. The cell suspension was ﬁl-
tered through a 100 lm cell strainer and washed with PBS. Cells
were resuspended in chondrocyte expansion medium, consisting
of DMEM, supplemented with 10% fetal bovine serum, 100 U ml1
penicillin, 100 lg ml1 streptomycin and 10 ng ml1 bFGF. Cells
were then counted and seeded in 175 cm3 culture ﬂasks at a den-
sity of 5000 cells cm2 in expansion medium and maintained in a
humidiﬁed incubator (37 C, 5% CO2). After the ﬁrst passage
(t = 10 days), the chondrocytes were detached using 0.25% trypsinand embedded into the alginate/dex-HEMA solutions. Expanded
chondrocytes were combined with IPNs (A3D108, A3D1012 and
A3D1016) at a density of 1.0  107 cells ml1. For IPN bead cultures,
the polymer solution, containing Irgacure, was dripped with a 23G
needle into 100 mM CaCl2 solution supplemented with 10 mM
HEPES pH 7.4. Subsequently, IPNs were formed by 5 min of UV
exposure of the beads. The resulting IPN beads were then cultured
in differentiation medium (DMEM supplemented with 0.2 mM
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100 U ml1 penicillin and 100 lg ml1 streptomycin and 5 ng ml1
TGF-b2) for up to 4 weeks. Medium was replaced every 2–3 days.Fig. 3. Storage modulus, G0 , at 1 Hz, of gels: () A3D108; (d) A3D158; (N) A3D208 as a
function of time. UV irradiation was started at 180 s, as indicated by the arrow.2.2.9. Cell viability and differentiation
Live/dead viability assay (Molecular Probes MP03224, Eugene,
USA) was performed according to the manufacturer’s recommen-
dations. The samples were examined using a light microscope
(Olympus, BX51, USA) and photomicrographs were taken with an
Olympus DP70 camera (USA). The excitation/emission ﬁlters were
set at 488/530 nm to observe living (green) cells and at 530/
580 nm to detect dead (red) cells.
For the evaluation of cellular differentiation, samples were
dehydrated through graded ethanol series, cleared in xylene and
embedded in parafﬁn. Embedded samples were sectioned to yield
5 lm sections, which were stained using either haematoxylin and
eosin or a triple stain of haematoxylin, fast green FCF (0.001% w/v)
and safranin O (0.1% w/v). The sections were examined using a
light microscope (Olympus, BX51, USA) and photomicrographs ta-
ken with an Olympus DP70 camera (USA). For immunolocalization
of collagen type II, sections were rehydrated and endogenous per-
oxidase activity was blocked using a 0.3% H2O2 solution for 10 min.
Samples were then washed with PBS/Tween 20 (0.1%) for 5 min,
blocked with 5% BSA in PBS for 30 min and incubated overnight
with anti-collagen type II (1:100, II-6B3II, Developmental Studies
Hybridoma Bank, USA) antibodies. Samples were then incubated
for 60 min with the secondary HRP-conjugated goat anti-mouse
antibody (1:200, Dako, USA). Staining was visualized using DAB
solution for 10 min. Counterstaining was performed with hema-
toxylin. The sections were examined using a light microscope. Iso-
type controls were performed by using mouse isotype IgG1
monoclonal antibody at concentrations similar to those used for
the stainings.Fig. 4. Young’s moduli (E0) at 1 Hz of different hydrogels: (h) D10; ( ) A3D10; ( )
D20; (j) A3D20. E0 of Alg-Ca is not reported because this hydrogel was too weak.3. Results and discussion
3.1. Physico-chemical characterization of hydrogels
In Fig. 2A the mechanical spectra of Alg-Ca gel as well as
semi-IPNs composed of Alg-Ca and dextran or dex-HEMA (DS = 8,
different polymer concentrations) are reported. G0 and G0 0 for the
different samples showed a slight dependence from frequency;
moreover, the storage moduli were higher than the viscous ones
in the whole range of analyzed frequencies and quite parallel each
other, thus demonstrating that the semi-IPNs behave like weak
hydrogels. The formulation behaves as a plastic system, i.e. a gel
at low shear forces, but a liquid at high shear forces due to revers-
ible breaking of the cross-links. Fig. 2A also shows that when dex-
tran was dissolved in the Alg-Ca network a slight increase in G0 was
observed, which might be explained by the higher polymer con-
centration of the semi-IPN compared to the Alg-Ca gel. Fig. 2B
clearly shows that, at ﬁxed dex-HEMA concentration, G0 decreased
with increasing degree of HEMA substitution. The decrease in G0 of
the Alg-Ca/dex-HEMA semi-IPNs with increasing dex-HEMA con-
centration (Fig. 2A) and increasing DS suggests a disturbing effect
of the HEMA moieties on the ‘‘egg-box’’ of the Alg-Ca network, as
also found in a previous study on semi-IPNs based on Alg-Ca and
another methacrylate derivative of dextran [19]. Because of the
low hydrogel strength, the semi-IPNs allow extrusion through a
needle, which is an important handling property for in situ hydro-
gel-forming applications.
The semi-IPNs can be transformed into IPNs by means of UV
exposure in the presence of a photoinitiator. In Fig. 3, the G0 behav-
ior upon UV irradiation of the A3D108, A3D158 and A3D208 samples
are shown. The storage moduli, G0, of the samples increased veryrapidly when the UV light was switched on (after 180 s from the
start of the experiment), reaching an upper plateau level within
10 s. In this short time, the HEMA groups polymerize upon irradi-
ation, leading to a chemically cross-linked dex-HEMA network
entangled in the Alg-Ca physical network. It should be emphasized
that UV polymerization resulted in an increase of the elastic mod-
uli of the samples of more than one order of magnitude. Fig. 3 also
shows that, as expected, the higher the dex-HEMA concentration,
the higher the G0 values are, as the cross-link density increases.
We investigated whether the hydrogel strength can be modu-
lated by varying the DS of dex-HEMA. The values of the Young
moduli, E0, at 1 Hz, of different IPNs are reported in Fig. 4; for com-
parison, E0 of the dex-HEMA hydrogels are also reported. Fig. 4
shows that the IPNs had higher E0 values than the corresponding
dex-HEMA hydrogels. As the polymer concentration increases the
E0 values increase correspondingly, as also seen for G0 (Fig. 3). It
should be emphasized that the hydrogel strengths of the IPNs are
greater than the sum of the dex-HEMA and Alg-Ca moduli. It sug-
gests a synergistic interaction between the two interpenetrating
polymer networks.
The homogeneity of the IPNs was investigated by soaking the
IPNs in an EDTA solution which results in dissolution of the Alg-
Ca network. DMA analysis showed that the EDTA treatment re-
sulted in a substantial drop in E0 (e.g. from 80 to 45 kPa for the
A3D2012 IPN). Importantly, the resulting weaker hydrogels main-
tained the original shape, indicating that a homogeneous chemical
network of dex-HEMA was formed after UV curing.
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both the dex-HEMA hydrogels and the IPNs was >95%, indicating
that the UV-photopolymerization was very effective and, impor-
tantly, the Alg-Ca network did not inhibit the polymerization of
the HEMA moieties.3.2. Hydrogel swelling and degradation
Fig. 5A shows that at pH 7.4 and 37 C , the A3D108 IPN swelled
substantially (almost three times its original weight within 8 days)
while the solvent absorption of the D108 hydrogel was lower (two
times weight increase in 10 days, Fig. 5B). The higher swelling of
the IPN can be ascribed to the higher water-absorbing capacity of
Alg-Ca network, which is more hydrophilic than the dex-HEMA
hydrogel. Fig. 5A and B also shows that this effect is more pro-
nounced for IPNs with a low DS. In previous studies, it has been re-
ported that at high DS, dex-HEMA gels hardly show swelling due to
the relatively high cross-link density [26]. Obviously, in such
highly cross-linked hydrogels the Alg-Ca had a low contribution
to the swelling capacity of the IPNs.
Fig. 5A shows that the IPNs degradation is inﬂuenced by the
polymer concentration and the DS of the dex-HEMA. A3D108 and
A3D208 IPNs showed complete degradation in about 15–18 days,
depending on the polymer concentration. The A3D1210 and
A3D1220 IPNs fully degraded in about 30 and 60 days, respectively,
while the IPNs with the highest DS degraded in 70–180 days. As
expected, increasing both the dex-HEMA concentration and the
DS resulted in increased degradation times, which can be attributedFig. 5. Swelling and degradation proﬁles of (A) IPNs (N) A3D108; (N) A3D208; (h)
A3D1012; (j) A3D2012; (s) A3D1016; (d) A3D2016; (B) dex-HEMA hydrogels (e)
D108; (.) D2016, in 100 mM HEPES buffer at 37 C, pH 7.4.to the higher cross-link density of the IPNs [22,27]. It appears that
the degradation time of the IPNs and the corresponding dex-HEMA
hydrogels is about the same. The presence of the alginate network
therefore does not affect the degradation rate of the hydrolytically
sensitive carbonate esters in the cross-links of the chemical dex-
HEMA network.3.3. Protein release
Fig. 6A shows that the A3D1016 and A3D2016 IPNs displayed a
sustained release of BSA for more than 300 h. Surprisingly, the pro-
tein showed the same release kinetics in both hydrogels, while a
slower release was expected for the IPN with the higher dex-HEMA
concentration. Both hydro gels however show a considerable
swelling (Fig. 6A, insert), which obviously resulted in an IPN in
which the pores are presumably larger than the hydrodynamic
diameter of the protein molecule, allowing its free diffusion in
the IPN. The release curves were ﬁtted to the Ritger–Peppas equa-
tion [28]:
Mt=M1 ¼ ktn
where Mt/M1 represents the fractional release of the loaded
protein, k is a kinetic constant, t is the release time and n is the dif-
fusional exponent. Analysis showed that the n-value was 0.46,
demonstrating that the release is essentially governed by Fickian
diffusion, supporting the suggestion that the pores of the IPNs
are larger than the hydrodynamic diameter of BSA.Fig. 6. BSA release in HEPES buffer, 100 mM, pH 7.4 at 37 C: (A) (.) A3D1016 and
(j) A3D2016; and (B) (s) D2016 and (j) A3D2016.
Fig. 7. Cell viability assay (stains live cells green and dead cells red), of A3D108 (A) and A3D1016 (B) chondrocyte-seeded IPN hydrogels after 4 days of in vitro culture. Scale bar
represents 100 lm.
Fig. 8. Safranin O staining (A, B, and C; stains proteoglycans red) and immunolocalization of chondrogenic marker collagen type II (D, E, and F; brown) of A3D108 (A and D),
A3D1012 (B and E) and A3D1016 (C and F) chondrocyte-seeded IPN hydrogels after 4 weeks of in vitro culture. Scale bar represents 50 lm (A–C) or 100 lm (D–F).
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and A3D2016 are reported. The ﬁrst mentioned hydrogel showed
a burst release of about 35%, which might be explained by the
observation that after polymerization the formed hydrogel ex-
pelled some water. The Alg3-Ca, instead, showed a low burst
whereas a complete protein release was observed in 24 h. The pro-
tein release from the IPN is a superposition of the behavior of the
IPN ‘‘building blocks’’ (Alg-Ca and dex-HEMA hydrogels). In fact,
theA3D2016 IPN showed a low burst effect, as the Alg-Ca network,
and a slow release, governed by the dex-HEMA network.3.4. Cell encapsulation experiments
Cell therapy is currently clinically applied, for example, to treat
cartilage defects [29]. Such technologies require the in vitro expan-
sion of the patient’s cells (chondrocytes) to obtain sufﬁcient num-
bers to treat the defect. During the expansion, chondrocytes lose
their chondrogenic phenotype, which is termed dedifferentiation.
This process is associated with the acquisition of a ﬁbroblast-like
appearance, the loss of proteoglycan production and a switch in
collagen synthesis from type II to type I [30]. Therefore, to evaluate
cytocompatibility and chondrogenic behavior of the IPNs, in vitro
expanded chondrocytes were seeded and cultured in beads of a se-
lected number of compositions of IPNs (A3D108, A3D1012 and
A3D1016). Upon encapsulation of the chondrocytes in the IPN
beads, a uniform distribution of cells was observed (Fig. 7). After
4 days of culture, cell viability in the hydrogels was approximately
60–70%, regardless of the composition (Fig. 7). No difference in cell
survival between photopolymerized and non-photopolymerizedgroups was observed (data not shown), which is in line with previ-
ously published reports [31,32].
The IPNs preserved their shape for the entire course of culture
(4 weeks). It should, however, be speciﬁed that this period is longer
than the degradation time described in this paper (Fig. 5A) because
of the higher Ca2+ concentration used to prepare these gels. With
culture time, increasing numbers of cell clusters were observed
in the beads with increasing DS (Fig. 8A–C). In addition, the embed-
ded cells started to demonstrate signs of redifferentiation, as was
revealed by histological examination. The dedifferentiated chon-
drocytes regained their original round morphology (Fig. 8A–C)
and areas of positive safranin O staining were observed around
the cells and cell clusters, indicating the synthesis of new proteo-
glycan-rich matrix (Fig. 8A–C). Most intense staining for proteogly-
cans was observed around cell clusters in the A3D1016 beads
(Fig. 8C). It should be noted that the IPN also stains positive for saf-
ranin O, in line with previous reports on Alg-containing hydrogels
[33,34]. Positive staining for collagen type II, an additional com-
monly used marker of chondrogenic differentiation, was also found
(Fig. 8D–E) and was again most intense around the cells embedded
in A3D1016 (Fig. 8E).4. Conclusions
This paper reports on a novel class of hydrogels based on the
interpenetration of two polysaccharide networks. It is shown that
the semi-IPNs and the IPNs based on Alg-Ca and dex-HEMA are
suitable for in situ hydrogel-forming applications. The semi-IPNs
formed by dex-HEMA chains, with DS 8, 12 or 16, interfered with
the Alg-Ca network, resulting in gel formulations with good ﬂow
L. Pescosolido et al. / Acta Biomaterialia 7 (2011) 1627–1633 1633properties that can be easily injected. These viscous semi-IPNs can
be transformed into elastic IPNs using UV polymerization of dex-
HEMA. Furthermore, due to the hydrolytically sensitive carbonate
esters in the chemical dex-HEMA network, the IPNs were fully
degradable and their degradation time can be tailored by varying
the dex-HEMA concentration and/or dex-HEMA DS. The IPNs
showed a sustained release of BSA for more than 300 h. The IPN
showed in contrast to the dex-HEMA gel, a very small burst release.
Finally, IPN beads seeded with equine chondrocytes showed good
cell survival and differentiation. They can facilitate chondrogenic
differentiation, which is inﬂuenced by the DS. The IPNs based on
Alg-Ca and dex-HEMA have potential for applications in regenera-
tive medicine. In particular, they can be further optimized to en-
hance speciﬁc tissue formation by embedded cells by, for
example, the incorporation of speciﬁc binding sequences [35] or
the controlled release of bioactive compounds. Taken together,
the IPNs described in this paper are promising systems as inject-
able in situ forming hydrogels for protein delivery and tissue engi-
neering applications.
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